
Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
Cash and cash receivable balance of $20.9 million as of December 31, 2024, expected to fund operations, including clinical activities into 2027 Strengthened cash position expected to support the Company through first substantive data readout in …